William Gray

TitleProfessor
InstitutionThomas Jefferson University
DepartmentMedicine
Address132 S. 10th St.
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pietzsch JB, Geisler BP, Garner AM, Ryschon AM, Gray WA, Fujihara M, Schneider PA. Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study. J Comp Eff Res. 2024 Dec 02; e240055. PMID: 39620243.
      Citations:    
    2. Brodmann M, Gray WA, Schneider PA, Kurzmann-Guetl K, Schweiger L, Zeller T, Thieme M, Kilaru S, Bachinsky WB, Feldman RL, Holden A, Varcoe RL, Lansky AJ, Rosenfield K. Results of SurVeil Versus IN.PACT Admiral Paclitaxel Coated Balloons in Femoropopliteal Arteries: Outcomes of the Randomised TRANSCEND Study Through 24 Months. Eur J Vasc Endovasc Surg. 2024 Nov 28. PMID: 39615582.
      Citations:    
    3. Gray WA, Soga Y, Fujihara M, Iida O, Babaev A, Kawasaki D, Zeller T, O'Connor D, Jaff MR, Chavez AM, M?ller-H?lsbeck S. Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value. J Comp Eff Res. 2024 Apr 12; e240025. PMID: 38606556.
      Citations:    
    4. Parikh SA, Schneider PA, Mullin CM, Rogers T, Gray WA. Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis. Lancet. 2023 11 18; 402(10415):1848-1856. PMID: 37890499.
      Citations:    
    5. Holden A, Gou?ffic Y, Gray WA, Davis EJ, Weinberg I, Jaff MR. Hypoechoic Halo Imaging Findings Following Femoropopliteal Artery Stent?Implantation: Risk Factors and Clinical Outcomes. JACC Cardiovasc Interv. 2023 07 10; 16(13):1654-1664. PMID: 37438033.
      Citations:    
    6. Brodmann M, Werner M, Sood A, Gray WA. Treating post-angioplasty dissection in the femoropopliteal arteries using the tack endovascular system: Tack optimized balloon angioplasty II 24-month results. Vascular. 2024 Aug; 32(4):850-857. PMID: 36919606.
      Citations:    
    7. Gray WA, Cardenas J, Teigen CL. Evaluation of safety and efficacy of the S.M.A.R.T.? Flex Vascular Stent System (OPEN study). Catheter Cardiovasc Interv. 2022 11; 100(6):1078-1087. PMID: 36177491.
      Citations:    
    8. Tepe G, Brodmann M, Bachinsky W, Holden A, Zeller T, Mangalmurti S, Nolte-Ernsting C, Virmani R, Parikh SA, Gray WA. Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial. J Soc Cardiovasc Angiogr Interv. 2022 Jul-Aug; 1(4):100341. PMID: 39131928.
      Citations:    
    9. Gray WA, Griffiths RI, Elroy PWM, Amorosi SL, McGovern AM, Jaff MR, Akehurst R, M?ller-H?lsbeck S. Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention. J Med Econ. 2022 Jan-Dec; 25(1):880-887. PMID: 35703041.
      Citations:    
    10. Lyden SP, Brodmann M, Parikh SA, Krishnan P, Schroeder H, Werner M, Holden A, Ouriel K, Tarra T, Gray WA. Four-year patient-level pooled mortality analysis of the ILLUMENATE US Pivotal and EU randomized controlled trials. J Vasc Surg. 2022 02; 75(2):600-607. PMID: 34506898.
      Citations:    
    11. Vanderland M, Ooi YS, Gray WA. Device profile of the tack endovascular system? for the treatment of peripheral arterial disease: overview of safety and efficacy. Expert Rev Med Devices. 2021 Aug; 18(8):717-726. PMID: 34167412.
      Citations:    
    12. Iida O, Fujihara M, Kawasaki D, Mori S, Yokoi H, Miyamoto A, Kichikawa K, Nakamura M, Ohki T, Diaz-Cartelle J, M?ller-H?lsbeck S, Gray WA, Soga Y. 24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent. Cardiovasc Intervent Radiol. 2021 Sep; 44(9):1367-1374. PMID: 34235560.
      Citations:    
    13. Tepe G, Brodmann M, Werner M, Bachinsky W, Holden A, Zeller T, Mangalmurti S, Nolte-Ernsting C, Bertolet B, Scheinert D, Gray WA. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial. JACC Cardiovasc Interv. 2021 06 28; 14(12):1352-1361. PMID: 34167675.
      Citations:    
    14. M?ller-H?lsbeck S, Benko A, Soga Y, Fujihara M, Iida O, Babaev A, O'Connor D, Zeller T, Dulas DD, Diaz-Cartelle J, Gray WA. Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent. Cardiovasc Intervent Radiol. 2021 Mar; 44(3):368-375. PMID: 33225377.
      Citations:    
    15. Weissler EH, Narcisse DI, Rymer JA, Armstrong EJ, Secemsky E, Gray WA, Mustapha JA, Adams GL, Ansel GM, Patel MR, Jones WS. Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease. Vasc Endovascular Surg. 2021 Feb; 55(2):124-134. PMID: 33094679.
      Citations:    
    16. Vanderland M, Gray WA. Zilver PTX peripheral paclitaxel-eluting stent: a technology evaluation. Expert Opin Drug Deliv. 2020 10; 17(10):1335-1343. PMID: 32590919.
      Citations:    
    17. Adams G, Shammas N, Mangalmurti S, Bernardo NL, Miller WE, Soukas PA, Parikh SA, Armstrong EJ, Tepe G, Lansky A, Gray WA. Intravascular Lithotripsy for Treatment of Calcified Lower Extremity Arterial Stenosis: Initial Analysis of the Disrupt PAD III Study. J Endovasc Ther. 2020 Jun; 27(3):473-480. PMID: 32242768.
      Citations:    
    18. Golzar J, Soga Y, Babaev A, Iida O, Kawasaki D, Bachinsky W, Park J, Prem JT, Vermassen F, Diaz-Cartelle J, M?ller-H?lsbeck S, Gray WA. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent. J Endovasc Ther. 2020 04; 27(2):296-303. PMID: 31989856.
      Citations:    
    19. Gray WA, Cardenas JA, Brodmann M, Werner M, Bernardo NI, George JC, Lansky A. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study. JACC Cardiovasc Interv. 2019 12 09; 12(23):2375-2384. PMID: 31806218.
      Citations:    
    20. Soga Y, Fujihara M, Iida O, Kawasaki D, Hirano K, Yokoi H, Miyamoto A, Kichikawa K, Nakamura M, Ohki T, Diaz-Cartelle J, Gray WA, M?ller-H?lsbeck S. Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents. Cardiovasc Intervent Radiol. 2020 Feb; 43(2):215-222. PMID: 31690980.
      Citations:    
    21. Gray WA, Jaff MR, Parikh SA, Ansel GM, Brodmann M, Krishnan P, Razavi MK, Vermassen F, Zeller T, White R, Ouriel K, Adelman MA, Lyden SP. Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years. Circulation. 2019 10; 140(14):1145-1155. PMID: 31567024.
      Citations:    
    22. Gray WA. Key points to consider in the IMPERIAL trial - Author's reply. Lancet. 2019 06 22; 393(10190):2490. PMID: 31232366.
      Citations:    
    23. Armstrong EJ, Brodmann M, Deaton DH, Gray WA, Jaff MR, Lichtenberg M, Rundback JH, Schneider PA. Dissections After Infrainguinal Percutaneous Transluminal Angioplasty: A Systematic Review and Current State of Clinical Evidence. J Endovasc Ther. 2019 08; 26(4):479-489. PMID: 31204592.
      Citations:    
    24. Elmariah S, Ansel GM, Brodmann M, Doros G, Fuller S, Gray WA, Pinto DS, Rosenfield KA, Mauri L. Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study. Am Heart J. 2019 03; 209:88-96. PMID: 30685679.
      Citations:    
    25. Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, M?ller-H?lsbeck S. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet. 2018 10 27; 392(10157):1541-1551. PMID: 30262332.
      Citations:    
    26. M?ller-H?lsbeck S, Hopf-Jensen S, Keirse K, Zeller T, Schro? H, Diaz-Cartelle J, Gray WA. Eluvia drug-eluting vascular stent system for the treatment of symptomatic femoropopliteal lesions. Future Cardiol. 2018 05 01; 14(3):207-213. PMID: 29631434.
      Citations:    
    27. Bunte MC, Cohen DJ, Jaff MR, Gray WA, Magnuson EA, Li H, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Patarca R, Du J, Stoll HP, Massaro J, Safley DM. Long-term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3-year results from the STROLL study. Catheter Cardiovasc Interv. 2018 07; 92(1):106-114. PMID: 29521013.
      Citations:    
    28. Badri M, Shapiro T, Wang Y, Minges KE, Curtis JP, Gray WA. Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR. Catheter Cardiovasc Interv. 2018 11 01; 92(5):835-841. PMID: 29359497.
      Citations:    
    29. Gray WA, Garcia LA, Amin A, Shammas NW. Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry. Cardiovasc Revasc Med. 2018 07; 19(5 Pt A):506-511. PMID: 29331436.
      Citations:    
    30. Altit R, Gray WA. New Innovations in Drug-Eluting Stents for Peripheral Arterial Disease. Curr Cardiol Rep. 2017 10 12; 19(11):117. PMID: 29027096.
      Citations:    
    31. Sardar P, Chatterjee S, Aronow HD, Kundu A, Ramchand P, Mukherjee D, Nairooz R, Gray WA, White CJ, Jaff MR, Rosenfield K, Giri J. Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention: A Meta-Analysis of Clinical Trials. J Am Coll Cardiol. 2017 May 09; 69(18):2266-2275. PMID: 28473130.
      Citations:    
    32. Aronow HD, Collins TJ, Gray WA, Jaff MR, Kluck BW, Patel RA, Rosenfield KA, Safian RD, Sobieszczyk PS, Wayangankar SA, White CJ. SCAI/SVM expert consensus statement on carotid stenting: Training and credentialing for carotid stenting. Catheter Cardiovasc Interv. 2016 Feb 01; 87(2):188-99. PMID: 26602705.
      Citations:    
    33. Maehara A, Mintz GS, Shimshak TM, Ricotta JJ, Ramaiah V, Foster MT, Davis TP, Gray WA. Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries. EuroIntervention. 2015 May; 11(1):96-103. PMID: 25982651.
      Citations:    
    34. Gray WA, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Bachinsky W, Rivera E, Tauth J, Patarca R, Massaro J, Stoll HP, Jaff MR. S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes. J Vasc Interv Radiol. 2015 Jan; 26(1):21-8. PMID: 25454735.
      Citations:    
    35. Shishehbor MH, Venkatachalam S, Gray WA, Metzger C, Lal BK, Peng L, Omran HL, Blackstone EH. Experience and outcomes with carotid artery stenting: an analysis of the CHOICE study (Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes Through the Collection of Clinical Evidence). JACC Cardiovasc Interv. 2014 Nov; 7(11):1307-17. PMID: 25326747.
      Citations:    
    36. Molnar RG, Gray WA. Sustained patency and clinical improvement following treatment of atherosclerotic iliac artery disease using the Assurant cobalt iliac balloon-expandable stent system. J Endovasc Ther. 2013 Feb; 20(1):94-103. PMID: 23391088.
      Citations:    
    37. Gray WA, Simonton CA, Verta P. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel meeting on the ACCULINK and ACCUNET Carotid Artery Stent System. Circulation. 2012 May 08; 125(18):2256-64. PMID: 22566349.
      Citations:    
    38. Gray WA, Macdonald S, Schneider PA. Should Medicare reimbursement for carotid artery stenting be extended to standard and low risk symptomatic and asymptomatic patients with carotid stenosis? Vascular. 2012 Feb; 20(1):7-11. PMID: 22277741.
      Citations:    
    39. Gray WA, Rosenfield KA, Jaff MR, Chaturvedi S, Peng L, Verta P. Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study. JACC Cardiovasc Interv. 2011 Feb; 4(2):235-46. PMID: 21349464.
      Citations:    
    40. Waseda K, Hasegawa T, Ako J, Honda Y, Grube E, Whitbourn R, Ormiston J, O'Shaughnessy CD, Henry TD, Overlie P, Schwartz LB, Sudhir K, Chevalier B, Gray WA, Yeung AC, Fitzgerald PJ. Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials. Circ J. 2010 Nov; 74(11):2334-9. PMID: 20890052.
      Citations:    
    41. Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Am J Cardiol. 2008 Jan 01; 101(1):63-8. PMID: 18157967.
      Citations:    
    Gray's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (143)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _